Udo Hoffmann News Today

Data from randomized trial will advance evidence for evaluation and treatment of heart disease by studying actual disease, atherosclerosisDENVER--(BUSINESS WIRE)--Cleerly, the company working to create a new standard of care for the diagnosis of heart disease, today announced the TRANSFORM trial at the American Hear...

An announcement on partners to collaborate in the TRANSFORM trial was made today during the American Heart Association’s (AHA) 2023 Scientific Sessions. Data from the randomized control trial will advance evidence for evaluation and treatment of heart disease by studying actual disease: atherosclerosis.

February 23, 2021 Coronary computed tomographic angiography (CTA) may be as good as invasive coronary angiography (ICA) at predicting the long-term risk of adverse events in patients with non-ST-segment elevation acute coronary syndromes, according to a subanalysis of the VERDICT trial. “The key thing is that its pretty much equivalent whether you do an ICA or you do a CT to define the likelihood of events after the MI,” lead author Klaus F. Kofoed, MD, DmSc (University of Copenhagen, Denma...

New AI Algorithm Predicts Adverse Cardiovascular Events Written by AZoRoboticsFeb 1 2021 The term coronary artery calcification refers to the accumulation of calcified plaque in the arterial walls of the heart. This condition is a crucial predictor of unfavorable cardiovascular events, including heart attacks. Image Credit: Roman Zaiets/shutterstock While computed tomography (CT) scans can help detect coronary calcium, measuring the amount of plaque needs time, dedicated equipment, and radiolo...

Novel deep learning system can predict cardiovascular risk from CT scans Coronary artery calcification -- the buildup of calcified plaque in the walls of the hearts arteries -- is an important predictor of adverse cardiovascular events like heart attacks. Coronary calcium can be detected by computed tomography (CT) scans, but quantifying the amount of plaque requires radiological expertise, time and specialized equipment. In practice, even though chest CT scans are fairly common, calcium score ...

December 18, 2020 For the initial evaluation of low-risk patients with stable chest pain, anatomic testing—coronary CT angiography (CTA) with or without noninvasive fractional flow reserve (FFR)—is cost-effective compared with functional testing, a new analysis based on PROMISE trial data indicates. Over the course of a patient’s life, using CTA alone instead of functional testing would be cost-effective with an incremental cost-effectiveness ratio (ICER) of $2,743 per quality-adjusted li...